• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

一名维持性血液透析患者的新型冠状病毒肺炎相关急性呼吸窘迫综合征：关于每日血液透析、无创通气、托珠单抗、抗焦虑药和床旁超声的个体化治疗方法的病例报告

SARS-CoV-2-related ARDS in a maintenance hemodialysis patient: case report on tailored approach by daily hemodialysis, noninvasive ventilation, tocilizumab, anxiolytics, and point-of-care ultrasound.

作者信息

Galassi Andrea, Casanova Francesca, Gazzola Lidia, Rinaldo Rocco, Ceresa Marco, Restelli Elena, Giorgini Alessia, Birocchi Simone, Giovenzana Marco, Zoni Ulisse, Valli Federica, Massironi Laura, Belletti Sebastiano, Magagnoli Lorenza, Stucchi Andrea, Ippolito Michela, Carugo Stefano, Parazzini Elena, Cozzolino Mario

机构信息

Renal & Dialysis Unit S. Paolo Hospital ASST Santi Paolo e Carlo Milan Italy.

Internal Medicine Unit S. Paolo Hospital ASST Santi Paolo e Carlo Milan Italy.

出版信息

Clin Case Rep. 2020 Dec 4;9(2):694-703. doi: 10.1002/ccr3.3623. eCollection 2021 Feb.

DOI:10.1002/ccr3.3623
PMID:33362933
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7753751/
Abstract

Without rescue drugs approved, holistic approach by daily hemodialysis, noninvasive ventilation, anti-inflammatory medications, fluid assessment by bedside ultrasound, and anxiolytics improved outcomes of a maintenance hemodialysis patient affected by severe COVID-19.

摘要

在没有获批的抢救药物的情况下，通过每日血液透析、无创通气、抗炎药物、床边超声进行液体评估以及使用抗焦虑药的整体治疗方法改善了一名受重症COVID-19影响的维持性血液透析患者的预后。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b649/7869377/46b2d3f86dae/CCR3-9-694-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b649/7869377/1836dbb5b280/CCR3-9-694-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b649/7869377/902e2a718b3a/CCR3-9-694-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b649/7869377/f0cacf0167dc/CCR3-9-694-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b649/7869377/46b2d3f86dae/CCR3-9-694-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b649/7869377/1836dbb5b280/CCR3-9-694-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b649/7869377/902e2a718b3a/CCR3-9-694-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b649/7869377/f0cacf0167dc/CCR3-9-694-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b649/7869377/46b2d3f86dae/CCR3-9-694-g004.jpg

相似文献

1
SARS-CoV-2-related ARDS in a maintenance hemodialysis patient: case report on tailored approach by daily hemodialysis, noninvasive ventilation, tocilizumab, anxiolytics, and point-of-care ultrasound.一名维持性血液透析患者的新型冠状病毒肺炎相关急性呼吸窘迫综合征：关于每日血液透析、无创通气、托珠单抗、抗焦虑药和床旁超声的个体化治疗方法的病例报告
Clin Case Rep. 2020 Dec 4;9(2):694-703. doi: 10.1002/ccr3.3623. eCollection 2021 Feb.
2
Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.COVID-19 住院成人患者使用伊马替尼的安全性和疗效：一项随机对照试验研究方案的结构化总结。
Trials. 2020 Oct 28;21(1):897. doi: 10.1186/s13063-020-04819-9.
3
Lung ultrasound-guided treatment for acute respiratory distress syndrome in a critically ill patient with severe COVID-19: a case report.COVID-19 重症患者急性呼吸窘迫综合征的肺部超声引导治疗：病例报告。
Ann Palliat Med. 2022 Dec;11(12):3794-3803. doi: 10.21037/apm-22-1319.
4
Effective treatment with Tocilizumab in a COVID-19 patient on maintenance hemodialysis: A case report.托珠单抗治疗维持性血液透析 COVID-19 患者的疗效：一例报告。
CEN Case Rep. 2021 Aug;10(3):364-369. doi: 10.1007/s13730-021-00577-y. Epub 2021 Jan 27.
5
COVID-19 Outbreak in an Urban Hemodialysis Unit.城市血液透析单元中的 COVID-19 疫情爆发。
Am J Kidney Dis. 2020 Nov;76(5):690-695.e1. doi: 10.1053/j.ajkd.2020.07.001. Epub 2020 Jul 15.
6
A prospective, randomised, double blind placebo-controlled trial to evaluate the efficacy and safety of tocilizumab in patients with severe COVID-19 pneumonia (TOC-COVID): A structured summary of a study protocol for a randomised controlled trial.一项旨在评估托珠单抗治疗重症 COVID-19 肺炎患者的疗效和安全性的前瞻性、随机、双盲、安慰剂对照试验（TOC-COVID）：一项随机对照试验研究方案的结构化总结。
Trials. 2020 Jun 3;21(1):470. doi: 10.1186/s13063-020-04447-3.
7
Therapeutic efficacy, mechanical ventilation, length of hospital stay, and mortality rate in severe COVID-19 patients treated with tocilizumab.托珠单抗治疗重症 COVID-19 患者的疗效、机械通气、住院时间和死亡率。
Int J Clin Pract. 2021 Jun;75(6):e14079. doi: 10.1111/ijcp.14079. Epub 2021 Mar 17.
8
Treatment of severely ill COVID-19 patients with anti-interleukin drugs (COV-AID): A structured summary of a study protocol for a randomised controlled trial.抗白细胞介素药物治疗重症 COVID-19 患者（COV-AID）：一项随机对照试验研究方案的结构化总结。
Trials. 2020 Jun 3;21(1):468. doi: 10.1186/s13063-020-04453-5.
9
Rapid and Impressive Response to a Combined Treatment with Single-Dose Tocilizumab and NIV in a Patient with COVID-19 Pneumonia/ARDS.COVID-19 肺炎/ARDS 患者采用托珠单抗单剂量联合 NIV 治疗取得快速显著疗效。
Medicina (Kaunas). 2020 Jul 27;56(8):377. doi: 10.3390/medicina56080377.
10
A case of COVID-19 reinfection in a hemodialysis patient: the role of antibody in SARS-CoV-2 infection.一例 COVID-19 再感染病例：抗体在 SARS-CoV-2 感染中的作用。
CEN Case Rep. 2022 Nov;11(4):422-427. doi: 10.1007/s13730-022-00697-z. Epub 2022 Mar 9.

引用本文的文献

1
Inferior vena cava ultrasound and other techniques for assessment of intravascular and extravascular volume: an update.下腔静脉超声及其他评估血管内和血管外容量的技术：最新进展
Clin Kidney J. 2023 Jun 29;16(11):1861-1877. doi: 10.1093/ckj/sfad156. eCollection 2023 Nov.
2
Forced diuresis oriented by point-of-care ultrasound in cardiorenal syndrome type 5 due to light chain myeloma-The role of hepatic venogram: A case report.床旁超声引导下的强制利尿在轻链型骨髓瘤所致5型心肾综合征中的应用——肝静脉造影的作用：一例报告
Clin Case Rep. 2021 Mar 16;9(4):2453-2459. doi: 10.1002/ccr3.4069. eCollection 2021 Apr.

本文引用的文献

1
Effects of a medium cut-off (Theranova) dialyser on haemodialysis patients: a prospective, cross-over study.中通量（Theranova）透析器对血液透析患者的影响：一项前瞻性交叉研究。
Clin Kidney J. 2019 Nov 11;14(1):382-389. doi: 10.1093/ckj/sfz155. eCollection 2021 Jan.
2
Combination of Inferior Vena Cava Diameter, Hepatic Venous Flow, and Portal Vein Pulsatility Index: Venous Excess Ultrasound Score (VEXUS Score) in Predicting Acute Kidney Injury in Patients with Cardiorenal Syndrome: A Prospective Cohort Study.下腔静脉直径、肝静脉血流和门静脉搏动指数的联合：静脉超负荷超声评分（VEXUS评分）预测心肾综合征患者急性肾损伤：一项前瞻性队列研究
Indian J Crit Care Med. 2020 Sep;24(9):783-789. doi: 10.5005/jp-journals-10071-23570.
3
Steroids: A Therapeutic Option for COVID-19 Pneumonia Patients With ESRD?
类固醇：终末期肾病的新冠病毒肺炎患者的一种治疗选择？
Kidney Int Rep. 2020 Jun 17;5(8):1375. doi: 10.1016/j.ekir.2020.05.031. eCollection 2020 Aug.
4
Current Overview on Hypercoagulability in COVID-19.新型冠状病毒肺炎患者高凝状态的研究现状。
Am J Cardiovasc Drugs. 2020 Oct;20(5):393-403. doi: 10.1007/s40256-020-00431-z.
5
Medical Management of COVID-19: Evidence and Experience.新型冠状病毒肺炎的医学管理：证据与经验
J Clin Med Res. 2020 Jun;12(6):329-343. doi: 10.14740/jocmr4201. Epub 2020 Jun 4.
6
Role of point-of-care ultrasound during the COVID-19 pandemic: our recommendations in the management of dialytic patients.即时超声在COVID-19大流行期间的作用：我们对透析患者管理的建议。
Ultrasound J. 2020 Jun 3;12(1):30. doi: 10.1186/s13089-020-00177-4.
7
Need for Objective Assessment of Volume Status in Critically Ill Patients with COVID-19: The Tri-POCUS Approach.急需对 COVID-19 危重症患者的容量状态进行客观评估：三焦点超声评估方法。
Cardiorenal Med. 2020;10(4):209-216. doi: 10.1159/000508544. Epub 2020 May 27.
8
COVID-19: clinical course and outcomes of 36 hemodialysis patients in Spain.COVID-19：西班牙 36 名血液透析患者的临床病程和转归。
Kidney Int. 2020 Jul;98(1):27-34. doi: 10.1016/j.kint.2020.04.031. Epub 2020 May 11.
9
A report from the Brescia Renal COVID Task Force on the clinical characteristics and short-term outcome of hemodialysis patients with SARS-CoV-2 infection.布雷西亚肾脏 COVID 工作组关于 SARS-CoV-2 感染血液透析患者的临床特征和短期结局的报告。
Kidney Int. 2020 Jul;98(1):20-26. doi: 10.1016/j.kint.2020.04.030. Epub 2020 May 8.
10
Management of acute kidney injury in patients with COVID-19.COVID-19 患者急性肾损伤的管理。
Lancet Respir Med. 2020 Jul;8(7):738-742. doi: 10.1016/S2213-2600(20)30229-0. Epub 2020 May 14.